Drug Profile
Research programme: ROR-gamma-t antagonists - Phenex Pharmaceuticals/Janssen
Alternative Names: RORγt inhibitors - Phenex PharmaceuticalsLatest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator Phenex Pharmaceuticals
- Class Antipsoriatics; Antirheumatics; Small molecules
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Multiple sclerosis; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Multiple-sclerosis in Germany
- 28 Aug 2021 No recent reports of development identified for preclinical development in Psoriasis in Germany
- 28 Aug 2021 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in Germany